Research Article
BibTex RIS Cite

Evaluation of functional role of miR-214-3p in Ewing sarcoma cell lines

Year 2020, Volume: 1 Issue: 2, 23 - 27, 28.06.2020

Abstract

Introduction/Aim: Ewing sarcoma is a malignant bone tumor in childhood, of neural origin. MicroRNAs (miRNA) have important roles in cancer pathogenesis. Since almost half of the identified human miRNAs are located in the fragile parts of the genome, these small molecules are thought to play a biomarker role in cancer progression. In this study, it was aimed to investigate the functional role of miR-214-3p on Ewing sarcoma progression in cell lines.

Material and Method: TC-71, TC-106 and CHLA-99 Ewing sarcoma cell lines were used in the study and Realtime PCR was used to investigate the functional role of mimic miR-214-3p, a tumor suppressor miRNA, and mir-214-3p levels in cells were determined. Within the scope of functional in vitro studies, proliferation, migration, invasion and apoptosis assay studies were carried out.

Findings/Results: It was found that miR-214-3p decreased significantly in the TC106 cell line, but not significantly changed in the TC71 and CHLA99 cell lines. It has been determined that miR-214-3p decreased from advanced functional studies in TC106 cells with proliferation, migration, invasion and apoptosis assay studies.

Conclusion: In line with our results of this study, in which we examined the possible function of miR ‐ 214 in cell lines in Ewing sarcoma it was found, for the first time in the literature, that miR‐ 214-3p had a low expression level in Ewing sarcoma cell lines and had a tumor suppressor effect.

References

  • Referanslar 1. Applebaum MA, Goldsby R, Neuhaus J, DuBois SG. Clinical features and outcomes in patients with secondary Ewing sarcoma. Pediatr Blood Cancer. 2013;60(4):611-5. 2. Gore L, DeGregori J, Porter CC. Targeting developmental pathways in children with cancer: what price success? Lancet Oncol. 2013;14(2):e70-8. 3. Guzel E, Okyay TM, Yalcinkaya B, Karacaoglu S, Gocmen M, Akcakuyu MH. Tumor suppressor and oncogenic role of long non-coding RNAs in cancer. North Clin Istanb. 2020;7(1):81-6. 4. Suer I, Guzel E, Karatas OF, Creighton CJ, Ittmann M, Ozen M. MicroRNAs as prognostic markers in prostate cancer. Prostate. 2019;79(3):265-71. 5. Yilmaz SS, Guzel E, Karatas OF, Yilmaz M, Creighton CJ, Ozen M. MiR-221 as a pre- and postoperative plasma biomarker for larynx cancer patients. Laryngoscope. 2015;125(12):E377-81. 6. Lotterman CD, Kent OA, Mendell JT. Functional integration of microRNAs into oncogenic and tumor suppressor pathways. Cell Cycle. 2008;7(16):2493-9. 7. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005;33(4):1290-7. 8. Bar-Eli M. Searching for the 'melano-miRs': miR-214 drives melanoma metastasis. EMBO J. 2011;30(10):1880-1. 9. Yang Z, Chen S, Luan X, Li Y, Liu M, Li X, et al. MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life. 2009;61(11):1075-82. 10. Tanoğlu EG, Öztürk Ş. Ewing Sarkoma ile Primitif Nöroektodermal Tümör Hücre Hatlarında Agresiflik Paterninin Karşılaştırılması. Kocaeli Med J. 2020;9; 1:24-31. 11. Li D, Liu J, Guo B, Liang C, Dang L, Lu C, et al. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nat Commun. 2016;7:10872. 12. Zhang XJ, Ye H, Zeng CW, He B, Zhang H, Chen YQ. Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J Hematol Oncol. 2010;3:46. 13. Kuninty PR, Bojmar L, Tjomsland V, Larsson M, Storm G, Östman A, et al. MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor. Oncotarget. 2016;7(13):16396-408. 14. Yang L, Zhang L, Lu L, Wang Y. miR-214-3p Regulates Multi-Drug Resistance and Apoptosis in Retinoblastoma Cells by Targeting ABCB1 and XIAP. Onco Targets Ther. 2020;13:803-11. 15. Liu F, Lou K, Zhao X, Zhang J, Chen W, Qian Y, et al. miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10. Int J Mol Med. 2018;42(6):3027-36. 16. Zhao X, Wang Q, Lin F, Wang X, Wang Y, Wang J, et al. RNA Sequencing of Osteosarcoma Gene Expression Profile Revealed that miR-214-3p Facilitates Osteosarcoma Cell Proliferation via Targeting Ubiquinol-Cytochrome c Reductase Core Protein 1 (UQCRC1). Med Sci Monit. 2019;25:4982-91. 17. Huang HJ, Liu J, Hua H, Li SE, Zhao J, Yue S, et al. MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis. Oncotarget. 2014;5(8):2161-75.

Ewing sarkoma hücre hatlarında miR-214-3p’nin fonksiyonel rolünün değerlendirilmesi

Year 2020, Volume: 1 Issue: 2, 23 - 27, 28.06.2020

Abstract

Giriş/Amaç: Ewing sarkoma, nöral orijinli çocukluk çağında kemikte görülen malign kemik tümörüdür. MikroRNA’ların (miRNA) kanser patogenezinde önemli rolleri vardır. Tanımlanan insan miRNA’larının yarısına yakınının genomun kırılgan yerlerinde bulunması nedeniyle bu küçük moleküllerin kanser progresyonunda biyobelirteç olarak rol alabileceği düşünülmektedir. Bu çalışmada, mir-214-3p’nin hücre hatlarında Ewing sarkoma progresyonu üzerindeki fonksiyonel rolünün araştırılması amaçlanmıştır.

Gereç ve Yöntem: Ewing sarkoma hücre hatlarından TC-71, TC-106, CHLA-99 çalışmada kullanıldı ve tümör süpresör miRNA olan mimik mir-214-3p’nin fonksiyonel rolünün araştırılması amacıyla Realtime PCR kullanıldı ve hücrelerdeki miR-214-3p düzeyleri tespit edildi. Fonksiyonel in vitro çalışmaları kapsamında proliferasyon, migrasyon, invazyon ve apoptoz assay çalışmaları gerçekleştirildi.

Bulgular: miR-214-3p’nin TC106 hücre hattında anlamlı düzeyde azalış gösterdiği, TC71 ve CHLA99 hücre hatlarında ise anlamlı olarak değişmediği tespit edildi. miR-214-3p’nin, TC106 hücrelerinde yapılan ileri fonksiyonel çalışmalardan proliferasyon, migrasyon, invazyon ve apoptoz assay çalışmalarıyla azalış gösterdiği tespit edilmiştir.

Sonuç: Ewing sarkomada miR‐214'ün hücre hatlarındaki olası fonksiyonunu incelediğimiz bu çalışmamızın sonuçlarımız doğrultusunda, literatürde ilk kez miR‐ 214-3p'nin Ewing sarkoma hücre hatlarında düşük ekspresyon seviyesine sahip olduğu ve tümör süpresör etki gösterdiği tespit edilmiştir.

References

  • Referanslar 1. Applebaum MA, Goldsby R, Neuhaus J, DuBois SG. Clinical features and outcomes in patients with secondary Ewing sarcoma. Pediatr Blood Cancer. 2013;60(4):611-5. 2. Gore L, DeGregori J, Porter CC. Targeting developmental pathways in children with cancer: what price success? Lancet Oncol. 2013;14(2):e70-8. 3. Guzel E, Okyay TM, Yalcinkaya B, Karacaoglu S, Gocmen M, Akcakuyu MH. Tumor suppressor and oncogenic role of long non-coding RNAs in cancer. North Clin Istanb. 2020;7(1):81-6. 4. Suer I, Guzel E, Karatas OF, Creighton CJ, Ittmann M, Ozen M. MicroRNAs as prognostic markers in prostate cancer. Prostate. 2019;79(3):265-71. 5. Yilmaz SS, Guzel E, Karatas OF, Yilmaz M, Creighton CJ, Ozen M. MiR-221 as a pre- and postoperative plasma biomarker for larynx cancer patients. Laryngoscope. 2015;125(12):E377-81. 6. Lotterman CD, Kent OA, Mendell JT. Functional integration of microRNAs into oncogenic and tumor suppressor pathways. Cell Cycle. 2008;7(16):2493-9. 7. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005;33(4):1290-7. 8. Bar-Eli M. Searching for the 'melano-miRs': miR-214 drives melanoma metastasis. EMBO J. 2011;30(10):1880-1. 9. Yang Z, Chen S, Luan X, Li Y, Liu M, Li X, et al. MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life. 2009;61(11):1075-82. 10. Tanoğlu EG, Öztürk Ş. Ewing Sarkoma ile Primitif Nöroektodermal Tümör Hücre Hatlarında Agresiflik Paterninin Karşılaştırılması. Kocaeli Med J. 2020;9; 1:24-31. 11. Li D, Liu J, Guo B, Liang C, Dang L, Lu C, et al. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nat Commun. 2016;7:10872. 12. Zhang XJ, Ye H, Zeng CW, He B, Zhang H, Chen YQ. Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J Hematol Oncol. 2010;3:46. 13. Kuninty PR, Bojmar L, Tjomsland V, Larsson M, Storm G, Östman A, et al. MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor. Oncotarget. 2016;7(13):16396-408. 14. Yang L, Zhang L, Lu L, Wang Y. miR-214-3p Regulates Multi-Drug Resistance and Apoptosis in Retinoblastoma Cells by Targeting ABCB1 and XIAP. Onco Targets Ther. 2020;13:803-11. 15. Liu F, Lou K, Zhao X, Zhang J, Chen W, Qian Y, et al. miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10. Int J Mol Med. 2018;42(6):3027-36. 16. Zhao X, Wang Q, Lin F, Wang X, Wang Y, Wang J, et al. RNA Sequencing of Osteosarcoma Gene Expression Profile Revealed that miR-214-3p Facilitates Osteosarcoma Cell Proliferation via Targeting Ubiquinol-Cytochrome c Reductase Core Protein 1 (UQCRC1). Med Sci Monit. 2019;25:4982-91. 17. Huang HJ, Liu J, Hua H, Li SE, Zhao J, Yue S, et al. MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis. Oncotarget. 2014;5(8):2161-75.
There are 1 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Research Articles [en] Araştırma Makaleleri [tr]
Authors

Esra Güzel Tanoğlu

Şükrü Öztürk 0000-0002-8809-7462

Publication Date June 28, 2020
Published in Issue Year 2020 Volume: 1 Issue: 2

Cite

AMA Güzel Tanoğlu E, Öztürk Ş. Ewing sarkoma hücre hatlarında miR-214-3p’nin fonksiyonel rolünün değerlendirilmesi. J Med Palliat Care / JOMPAC / jompac. June 2020;1(2):23-27.

TR DİZİN ULAKBİM and International Indexes (1d)

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]



google-scholar.png


crossref.jpg

f9ab67f.png

asos-index.png


COPE.jpg

icmje_1_orig.png

cc.logo.large.png

ncbi.png

ORCID_logo.png

pn6krf5.jpg


Our journal is in TR-Dizin, DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index, Eurasian Scientific Journal Index (ESJI), and Turkiye Citation Index.

EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation. 

Journal articles are evaluated as "Double-Blind Peer Review"